Integration of bio identical hormones with diet, exercise and whole food supplements reduces the risk of heart disease and breast cancer.

It is clear based on over 75 years of research pertaining to the risk factors for Heart Disease and Breast cancer in women, that the following well established practices should be a matter of course.
Begin with a healthy diet, as described by Ernest Wynder MD, of Sloan Kettering, the first doctor to prove a relationship of smoking and lung cancer, he stated that a whole food diet (like the one described by Nick Delgado PhD and Nathan Pritikin of 10-10-80) as a way to dramatically reduce prolactin and LDL cholesterol levels and woman at risk for breast cancer.

(1) James Barnard of UCLA published his findings of work with Nathan Pritikin and Nick Delgado of exercise and diet to combat heart disease and breast cancer. This beneficial outcome may be because we were reducing the abnormal metabolites of estrogen and testosterone conversion, such as 16 alpha Hydroxy Estrone while improving the good estrogen of the 2 OHE. (2) Although testosterone replacement may increase the downstream metabolites for estrogen in women, the use of DIM and Ic3 clears the problem along with a healthy diet and exercise. (3).
Indeed, hormone replacement, even if its bio Identical can increase abnormal metabolite activity, however when in the proper diet, exercise and supplementation, we see a positive outcome reducing risk factors of LDL cholesterol and prolactin levels related to a lower risk of breast cancer and heart disease. (4) The proper understanding of low testosterone and androgen deficiency must be treated otherwise female symptoms of fatigue, body fat gain in the abdomen, loss of libido, receptivity to sex, loss of bone density and lack of feelings of wellbeing will continue in our adult female population. (5) It is suggested the testosterone with estrogen pellets implants are likely a preferred method of enhanced hormone modulation in females as well as testosterone implants in men, with over 60 years of excellent clinical findings. More current findings show a lower risk of heart disease in those with bio identical hormone implants. (6) The confusion over the use of bio identical hormones and synthetic is not only related to oral vs. Transdermal vs. injection vs. pellet implants but also from lack of controls with diet, exercise and the needed preventative aspects of evidence that has been ignored by the women’s Health study of self reported use of hormones, low dosages of testosterone and assumptions about diet and activity in the study. (7) (8) (9)
Testosterone given to males or females by injection, or better yet by pellet implants, has no negative effect on lipids, cardiovascular risk factors, or PSA, especially when controlling for and using a diet high in fiber as described in the Delgado Protocol and exercise. The natural hormones of youth can restore many of the lost abilities of middle age and seniors with proper Endocrinological intervention, tests, examinations, and dosing with natural hormones combined with the herbs and fibers from whole food. (10) (11) (12) (13) (14). There is a new classification of herbal combinations that can naturally enhance testosterone while clearing harmful estrogens in both men and women. Also the increased immune function and healthy joints are likely to be noticed within less than 5 weeks of using Stem Cell Strong, with Stem 2 Go.

REFERENCES

(2) Effects of exercise and diet on chronic disease- Christian K. Roberts and R. James Barnard- J Appl Physiol 98: 3-30, 2005; doi:10.1152/japplphysiol.00852.2004
8750-7587/05

(3) Clinical Investigation and Reports:
Elevated HDL Cholesterol Is a Risk Factor for Ischemic Heart Disease in White Women When Caused by a Common Mutation in the Cholesteryl Ester Transfer Protein Gene
Birgit Agerholm-Larsen, MSc, PhD; Børge G. Nordestgaard, MD, DMSc; Rolf Steffensen, MD; Gorm Jensen, MD, DMSc; Anne Tybjærg-Hansen, MD, DMSc

(4) Hormone therapy and the rise and perhaps fall of US breast cancer incidence rates: critical reflections
Nancy Krieger , Department of Society, Human Development and Health, Harvard School of Public Health, Kresge 717, 677 Huntington Avenue, Boston, MA 02115, USA.

(5) What Is the Female Androgen Deficiency Syndrome?

(6) ML Stefanick - The American Journal of Medicine, 2005 - Elsevier
... 1943, Testosterone pellets implanted under the skin reported to improve ... for CHD was
the Wyeth-funded Heart and Estrogen/progestin Replacement Study

(7) Women who take a combination of estrogen and testosterone to treat the symptoms of menopause may have an increased risk of breast cancer, -July 24 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

(Arch Intern Med. 2006;166:1483-1489.

Journal of Women's Health Bioidentical Hormone Therapy: A Review of the Evidence
Michael Cirigliano. Journal of Women's Health. June 2007, 16(5): 600-631. doi:10.1089/jwh.2006.0311.

(8) Transdermal estradiol gel 0.1% for the treatment of vasomotor symptoms in postmenopausal women Richard E. Hedrick, Ronald T. Ackerman, William D. Koltun, Mark B. Halvorsen, Lawrence J. Lambrecht Menopause. Feb 2009, Vol. 16, No. 1: 132-140

CrossRef
Bioidentical hormone therapy: a panacea that lacks supportive evidence, Lisa A Boothby, Paul L Doering Current Opinion in Obstetrics and Gynecology. Sep 2008, Vol. 20, No. 4: 400-407

CrossRef
Ethical problems with bioidentical hormone therapy, M S Rosenthal
International Journal of Impotence Research. Feb 2008, Vol. 20, No. 1: 45-52

(9) Testosterone Spray for Female Libido – suggested testosterone was of no benefit compared to placebo, Tuesday, April 15, 2008 (Nick Delgado note- however a spray on the abdomen is inadequate as compared to other studies with Testosterone pellets in the abdomen).

Annals of Internal Medicine, April 14mContact: Lori J. Shanks
617-534-1604,JAMA and Archives Journals 24-Jul-2006

(10) References of Interest-Androgens (Including Testosterone) in Women

Use of androgens in postmenopausal women.
Davis SR, Burger HG. Current Opinion in Obstetrics and Gynecology. 1997 Jun; 9(3):
177-80. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=9263701
Curr Opin Obstet Gynecol. 1997 Jun;9(3):177-80.